V. Hébert

1.6k total citations
34 papers, 229 citations indexed

About

V. Hébert is a scholar working on Pathology and Forensic Medicine, Genetics and Rheumatology. According to data from OpenAlex, V. Hébert has authored 34 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 13 papers in Genetics and 12 papers in Rheumatology. Recurrent topics in V. Hébert's work include Autoimmune Bullous Skin Diseases (22 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers) and Urticaria and Related Conditions (12 papers). V. Hébert is often cited by papers focused on Autoimmune Bullous Skin Diseases (22 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers) and Urticaria and Related Conditions (12 papers). V. Hébert collaborates with scholars based in France, Germany and Japan. V. Hébert's co-authors include P. Joly, Pascal Joly, Sébastien Calbo, Maud Maho‐Vaillant, Marie-Laure Golinski, Olivier Boyer, Marie Petit, Gaëtan Riou, C. Mignard and Billal Tedbirt and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Journal of Investigative Dermatology.

In The Last Decade

V. Hébert

28 papers receiving 225 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Hébert France 9 155 111 109 35 32 34 229
Suying Feng China 8 180 1.2× 126 1.1× 151 1.4× 11 0.3× 42 1.3× 42 278
Ryosuke Sogame Japan 9 278 1.8× 179 1.6× 181 1.7× 56 1.6× 35 1.1× 11 322
Mong-Shang Lin United States 10 231 1.5× 164 1.5× 164 1.5× 44 1.3× 15 0.5× 17 308
C. Le Roux‐Villet France 8 245 1.6× 203 1.8× 176 1.6× 18 0.5× 14 0.4× 20 280
R. Nouira Tunisia 9 221 1.4× 142 1.3× 151 1.4× 45 1.3× 38 1.2× 25 314
Reine Moriuchi Japan 8 222 1.4× 194 1.7× 193 1.8× 10 0.3× 11 0.3× 16 266
S. Duvert‐Lehembre France 8 462 3.0× 384 3.5× 377 3.5× 42 1.2× 23 0.7× 18 490
Marleen M. Janson United States 8 221 1.4× 167 1.5× 189 1.7× 55 1.6× 10 0.3× 8 310
L. Gusdorf France 8 60 0.4× 27 0.2× 123 1.1× 63 1.8× 69 2.2× 20 273
J. Plée France 9 304 2.0× 252 2.3× 263 2.4× 16 0.5× 29 0.9× 17 380

Countries citing papers authored by V. Hébert

Since Specialization
Citations

This map shows the geographic impact of V. Hébert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Hébert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Hébert more than expected).

Fields of papers citing papers by V. Hébert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Hébert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Hébert. The network helps show where V. Hébert may publish in the future.

Co-authorship network of co-authors of V. Hébert

This figure shows the co-authorship network connecting the top 25 collaborators of V. Hébert. A scholar is included among the top collaborators of V. Hébert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Hébert. V. Hébert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aubert, H., et al.. (2025). Efficacy of upadacitinib in patients with severe alopecia areata, including baricitinib-refractory cases: A case series of 22 patients. Journal of the American Academy of Dermatology. 94(1). 269–271. 1 indexed citations
2.
Maho‐Vaillant, Maud, Christophe Arnoult, V. Hébert, et al.. (2025). Prevalence and pathogenic activity of anti-desmocollin-3 antibodies in patients with pemphigus vulgaris and pemphigus foliaceus. British Journal of Dermatology. 192(6). 1072–1082. 1 indexed citations
3.
Hébert, V., Maud Maho‐Vaillant, Corine Pérals, et al.. (2024). The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgaris. British Journal of Dermatology. 191(4). 605–615. 2 indexed citations
4.
5.
Ishii, Norito, et al.. (2023). Mixed muco-cutaneous pemphigoid: Clinical and immunological features of 15 cases. Frontiers in Immunology. 14. 1134720–1134720. 3 indexed citations
6.
Petit, Marie, Carole Burel, Maud Maho‐Vaillant, et al.. (2022). IgG N-glycosylation from Patients with Pemphigus Treated with Rituximab. Biomedicines. 10(8). 1774–1774. 6 indexed citations
7.
Golinski, Marie-Laure, Maud Maho‐Vaillant, Laurent Drouot, et al.. (2022). The Diversity of Serum Anti-DSG3 IgG Subclasses Has a Major Impact on Pemphigus Activity and Is Predictive of Relapses After Treatment With Rituximab. Frontiers in Immunology. 13. 849790–849790. 4 indexed citations
8.
Maho‐Vaillant, Maud, Corine Pérals, Marie-Laure Golinski, et al.. (2021). Rituximab and Corticosteroid Effect on Desmoglein-Specific B Cells and Desmoglein-Specific T Follicular Helper Cells in Pemphigus. Journal of Investigative Dermatology. 141(9). 2132–2140.e1. 18 indexed citations
9.
Petit, Marie, Damien Schapman, Marie-Laure Golinski, et al.. (2021). Longitudinal Pathogenic Properties and N-Glycosylation Profile of Antibodies from Patients with Pemphigus after Corticosteroid Treatment. Biomedicines. 9(10). 1411–1411. 2 indexed citations
10.
Hébert, V., Maud Maho‐Vaillant, Marie-Laure Golinski, et al.. (2021). Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid Regimen. Frontiers in Immunology. 12. 666022–666022. 8 indexed citations
11.
Gillibert, André, S. Duvert‐Lehembre, M. Alexandre, et al.. (2020). Sensitivity to change and correlation between the autoimmune bullous disease quality‐of‐life questionnaires ABQOL and TABQOL , and objective severity scores. British Journal of Dermatology. 183(5). 944–945. 8 indexed citations
12.
Lok, Catherine, et al.. (2020). Severe dapsone-induced hypoalbuminemia in a case of mucous membrane pemphigoid. JAAD Case Reports. 6(10). 1098–1100.
13.
Maho‐Vaillant, Maud, V. Hébert, Laurent Drouot, et al.. (2020). Caractérisation des auto-anticorps non spécifique de la desmogléine chez les patients atteints de pemphigus. Annales de Dermatologie et de Vénéréologie. 147(12). A75–A76.
14.
Castel, M., et al.. (2020). Pemphigoïde mixte muco-cutanée : caractéristiques cliniques et immunologiques. Annales de Dermatologie et de Vénéréologie. 147(12). A73–A74. 1 indexed citations
15.
Houivet, Estelle, V. Hébert, C. Richard, et al.. (2019). Risk factors for treatment failure in scabies. British Journal of Dermatology. 180(4). 1 indexed citations
16.
Lemoine, Mathilde, Aurore Curie, V. Hébert, et al.. (2019). Ipilimumab-induced renal granulomatous arteritis: a case report. BMC Nephrology. 20(1). 366–366. 10 indexed citations
17.
Hébert, V., et al.. (2019). Senegal, a new potential endemic country for Buruli ulcer?. International Journal of Infectious Diseases. 89. 128–130. 3 indexed citations
18.
Hébert, V., et al.. (2019). Linear IgA bullous dermatosis treated with rituximab. JAAD Case Reports. 5(2). 124–126. 12 indexed citations
19.
Hébert, V., Marie Petit, Maud Maho‐Vaillant, et al.. (2019). Modifications of the Transcriptomic Profile of Autoreactive B Cells From Pemphigus Patients After Treatment With Rituximab or a Standard Corticosteroid Regimen. Frontiers in Immunology. 10. 1794–1794. 18 indexed citations
20.
Hébert, V. & P. Joly. (2017). Rituximab in Pemphigus. Immunotherapy. 10(1). 27–37. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suying Feng Breakdown of academic impact, for papers by Ryosuke Sogame Breakdown of academic impact, for papers by Mong-Shang Lin Breakdown of academic impact, for papers by C. Le Roux‐Villet Breakdown of academic impact, for papers by R. Nouira Breakdown of academic impact, for papers by Reine Moriuchi Breakdown of academic impact, for papers by S. Duvert‐Lehembre Breakdown of academic impact, for papers by Marleen M. Janson Breakdown of academic impact, for papers by L. Gusdorf Breakdown of academic impact, for papers by J. Plée
Rankless by CCL
2026